Liver resection is one of the main curative options for early hepatocellular carcinoma (HCC)
in patients with cirrhosis and is the treatment of choice in non-cirrhotic patients. However …

Cancer markers are molecules produced by cancer cells which may serve to identify the
presence of cancer. Cancer markers can be differentiated as serum-based, radiology-based …

Simple Summary One of the major problems regarding hepatocellular carcinoma (HCC) is
the development of metastasis and recurrence, even in patients with an early stage …

Background The benefits and tolerability of transarterial chemoembolization (TACE)
combined with regorafenib as a second-line therapy has not been reported for unresectable …

UICC staging) and tumor size. Although this study is retrospective, it is of interest both by the
issue raised which is still contradictory and by the large size of the cohort studied by the …

Alpha-fetoprotein (AFP) is a glycoprotein that plays an important role in immune regulation
with critical involvement in early human development and maintaining the immune balance …

Background High alpha-fetoprotein (AFP) expressions (> 400 ng/mL) are associated with
poor oncological characteristics for hepatocellular carcinoma (HCC). However, prognosis …

Simple Summary A large percentage of patients with hepatocellular carcinoma (HCC) who
undergo surgical resection experience a recurrence of their disease. Therefore, predicting …

Background The clinical value of alpha-fetoprotein (AFP) in patients with AFP-negative (< 20
ng/ml) hepatocellular carcinoma (HCC) who underwent curative resection remained …

Hepatocellular carcinoma (HCC) has high recurrence rates exceeding 50% despite curative
resection. The serum biomarker alpha-fetoprotein (AFP) is a well-known prognostic marker …